查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722974

2025 年至 2033 年放射性皮膚炎市場規模、佔有率、趨勢及預測（按產品、配銷通路和地區）

Radiodermatitis Market Size, Share, Trends and Forecast by Product, Distribution Channel, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球放射性皮膚炎市場規模價值 5.1478 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 6.6802 億美元，2025 年至 2033 年的複合年成長率為 2.94%。亞太地區目前佔據市場主導地位，到 2024 年其市佔率將超過 34%。放射性皮膚炎的市場佔有率正在擴大，這得益於全球癌症患者數量的增加、治療方式的進步以及對非侵入性、以患者為中心的治療的需求不斷成長。

放射性皮膚炎或放射性皮膚炎是指因治療癌症的放射療法而引起的皮膚病。它通常作為癌症治療期間的副作用出現，或發生在乳腺癌、肺癌、皮膚癌、頸部癌、頭部癌或會陰癌患者接受介入放射學治療後，其中皮膚是治療靶區的一部分。一些常用的治療放射性皮膚炎的產品包括外用抗生素、皮質類固醇、親水性乳膏、水凝膠和水膠體敷料、矽膠塗層敷料、銀葉敷料、口服止痛藥和抗發炎藥物。近年來，放射性皮膚炎治療越來越受到人們的關注，因為它有助於減輕不適、減輕疼痛、防止中斷正在進行的治療，同時提高患者的整體生活品質。

放射性皮膚炎市場趨勢：

癌症的廣泛流行和放射療法作為治療選擇的日益普及是推動市場成長的主要因素。除此之外，全球老年人口的不斷增加以及對抗放射治療不良副作用的需求不斷成長，增加了對放射性皮膚炎治療的需求。此外，許多管理機構和非管理機構正在採取積極舉措，傳播對放射性皮膚炎治療和管理產品的意識。這與公共和私人對生命科學領域正在進行的研究和開發 (R&D) 活動的投資不斷增加相結合，催化了市場的成長。此外，領先的企業正專注於開發創新的產品變體，以擴大其產品組合併獲得競爭優勢。此外，臨床試驗數量的增加、政府的優惠政策、消費者支出能力的提高、醫療保健基礎設施的改善以及學名藥的易於獲得也是創造積極市場前景的其他一些因素。

本報告回答的關鍵問題

  • 放射性皮膚炎市場有多大？放射性皮膚炎市場的未來前景如何？
  • 推動放射性皮膚炎市場發展的關鍵因素有哪些？
  • 哪個地區佔據放射性皮膚炎最大的市佔率？
  • 全球放射性皮膚炎市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球放射性皮膚炎市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 外用
    • 關鍵部分
      • 皮質類固醇
      • 親水性乳膏
      • 抗生素
      • 其他
  • 口服
  • 敷料
    • 關鍵部分
      • 水凝膠和水膠體敷料
      • 無刺痛阻隔膜
      • 蜂蜜浸漬紗布
      • 矽膠塗層敷料
      • 其他

第7章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路藥局

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第9章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • Bausch Health Companies Inc.
    • Bayer AG
    • BMG PHARMA SpA
    • Charles River Laboratories International Inc.
    • ConvaTec Group plc
    • Helsinn Healthcare SA
    • ICON plc
    • Integra LifeSciences
    • Molnlycke Health Care AB
    • Stratpharma AG
Product Code: SR112025A5638

The global radiodermatitis market size was valued at USD 514.78 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 668.02 Million by 2033, exhibiting a CAGR of 2.94% from 2025-2033. Asia Pacific currently dominates the market, holding a market share of over 34% in 2024. The radiodermatitis market share is expanding, driven by the increasing numbers of cancer patients worldwide, heightened advancements in treatment modalities, and rising demand for the non-invasive, patient-centered treatments.

Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer. It generally occurs as a side effect during cancer treatment or after interventional radiology in patients with cancers of the breast, lungs, skin, neck, head or perineum region where the skin is part of the target field. Some of the commonly used products to treat radiodermatitis include topical antibiotics, corticosteroids, hydrophilic creams, hydrogel and hydrocolloid dressings, silicone-coated dressings, silver-leaf dressings, oral analgesics, and anti-inflammatory agents. In recent years, radiodermatitis treatment has gained traction as it helps reduce discomfort, minimize pain and prevent interruption in ongoing therapy while improving the overall quality of the patient's life.

Radiodermatitis Market Trends:

The widespread prevalence of cancer and the rising adoption of radiation therapy as a treatment option represent the primary factors driving the market growth. Besides this, the increasing geriatric population across the globe and the growing need to counter the adverse side effects of radiation therapy are augmenting the demand for radiodermatitis treatment. Additionally, numerous governing and non-governing agencies are taking favorable initiatives to spread awareness regarding the available radiodermatitis treatment and management products. This, in confluence with the rising public and private investments in the ongoing research and development (R&D) activities in the field of life sciences, is catalyzing the market growth. Furthermore, the leading players are focusing on developing innovative product variants to expand their product portfolio and gain a competitive edge. Moreover, the rising number of clinical trials, favorable government policies, increasing consumer expenditure capacities, improving healthcare infrastructure and easy availability of generic drugs are some of the other factors creating a positive market outlook.

Key Market Segmentation:

Breakup by Product:

  • Topical
  • Corticosteroids
  • Hydrophilic Creams
  • Antibiotics
  • Others
  • Oral
  • Dressings
  • Hydrogel and Hydrocolloid Dressings
  • No Sting Barrier Film
  • Honey Impregnated Gauze
  • Silicone Coated Dressings
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Molnlycke Health Care AB and Stratpharma AG.

Key Questions Answered in This Report

  • 1.How big is the radiodermatitis market?
  • 2.What is the future outlook of radiodermatitis market?
  • 3.What are the key factors driving the radiodermatitis market?
  • 4.Which region accounts for the largest radiodermatitis market share?
  • 5.Which are the leading companies in the global radiodermatitis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiodermatitis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Topical
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Corticosteroids
      • 6.1.2.2 Hydrophilic Creams
      • 6.1.2.3 Antibiotics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Oral
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dressings
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hydrogel and Hydrocolloid Dressings
      • 6.3.2.2 No Sting Barrier Film
      • 6.3.2.3 Honey Impregnated Gauze
      • 6.3.2.4 Silicone Coated Dressings
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Bausch Health Companies Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bayer AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 BMG PHARMA S.p.A.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Charles River Laboratories International Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 ConvaTec Group plc
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Helsinn Healthcare SA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 ICON plc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Integra LifeSciences
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Molnlycke Health Care AB
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis
    • 13.3.11 Stratpharma AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Radiodermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Radiodermatitis Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Radiodermatitis Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Radiodermatitis Market: Breakup by Distribution Channel (in %), 2024
  • Figure 6: Global: Radiodermatitis Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Radiodermatitis (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Radiodermatitis (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Radiodermatitis (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Radiodermatitis (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Radiodermatitis (Dressings) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Radiodermatitis (Dressings) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Radiodermatitis (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Radiodermatitis (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Radiodermatitis (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Radiodermatitis (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Radiodermatitis (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Radiodermatitis (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: North America: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: North America: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: United States: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: United States: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Canada: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Canada: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Asia-Pacific: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Asia-Pacific: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: China: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: China: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Japan: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Japan: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: India: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: India: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: South Korea: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: South Korea: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Australia: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Australia: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Indonesia: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Indonesia: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Others: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Others: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Europe: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Europe: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Germany: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Germany: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: France: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: France: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: United Kingdom: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: United Kingdom: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Italy: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Italy: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Spain: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Spain: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Russia: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Russia: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Latin America: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Latin America: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Brazil: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Brazil: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Mexico: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Mexico: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Middle East and Africa: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Middle East and Africa: Radiodermatitis Market: Breakup by Country (in %), 2024
  • Figure 67: Middle East and Africa: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Global: Radiodermatitis Industry: SWOT Analysis
  • Figure 69: Global: Radiodermatitis Industry: Value Chain Analysis
  • Figure 70: Global: Radiodermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiodermatitis Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Radiodermatitis Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Radiodermatitis Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 4: Global: Radiodermatitis Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Radiodermatitis Market: Competitive Structure
  • Table 6: Global: Radiodermatitis Market: Key Players